- Home
- VIR vs FFC Comparison
VIR vs FFC Comparison
Compare VIR & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- FFC
- Stock Information
- Founded
- VIR 2016
- FFC 1983
- Country
- VIR United States
- FFC United States
- Employees
- VIR N/A
- FFC N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- FFC Trusts Except Educational Religious and Charitable
- Sector
- VIR Health Care
- FFC Finance
- Exchange
- VIR Nasdaq
- FFC Nasdaq
- Market Cap
- VIR 844.9M
- FFC 741.9M
- IPO Year
- VIR 2019
- FFC N/A
- Fundamental
- Price
- VIR $5.23
- FFC $16.06
- Analyst Decision
- VIR Strong Buy
- FFC
- Analyst Count
- VIR 7
- FFC 0
- Target Price
- VIR $32.86
- FFC N/A
- AVG Volume (30 Days)
- VIR 1.4M
- FFC 164.1K
- Earning Date
- VIR 07-31-2025
- FFC 01-01-0001
- Dividend Yield
- VIR N/A
- FFC 6.79%
- EPS Growth
- VIR N/A
- FFC N/A
- EPS
- VIR N/A
- FFC N/A
- Revenue
- VIR $20,861,000.00
- FFC N/A
- Revenue This Year
- VIR N/A
- FFC N/A
- Revenue Next Year
- VIR N/A
- FFC N/A
- P/E Ratio
- VIR N/A
- FFC N/A
- Revenue Growth
- VIR N/A
- FFC N/A
- 52 Week Low
- VIR $4.32
- FFC $11.90
- 52 Week High
- VIR $14.45
- FFC $14.96
- Technical
- Relative Strength Index (RSI)
- VIR 50.23
- FFC 63.57
- Support Level
- VIR $5.02
- FFC $15.97
- Resistance Level
- VIR $5.34
- FFC $16.14
- Average True Range (ATR)
- VIR 0.25
- FFC 0.12
- MACD
- VIR 0.03
- FFC 0.01
- Stochastic Oscillator
- VIR 47.53
- FFC 86.44
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.